Overview: Urea Serum TestIntroduction: The Urea Serum Test measures urea in serum to diagnose kidney disease, causing fatigue or nausea. Aligned with 2023 NKF guidelines, it uses biochemical methods for high specificity, supporting renal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected kidney disease.
Other Names: Serum Urea Assay, Blood Urea Nitrogen (BUN) Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Serum urea testing began in the 1950s with kidney function research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures urea in serum to diagnose kidney disease, guides treatment, and evaluates patients with fatigue or nausea.
Test Parameters: 1. Urea Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of fatigue, nausea, or kidney symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, nausea, or history of kidney disease. Include current medications, especially diuretics.
Consent: Written consent required, detailing the tests purpose, kidney disease implications, and risks of sample collection.
Procedural Considerations: Uses enzymatic assays to measure urea levels in serum. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for kidney disease diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Dietary protein intake may alter levels.
Clinical Significance: Elevated urea confirms kidney disease, guiding dialysis or medical therapy. Normal levels may require creatinine or GFR testing.
Specialist Consultation: Consult a nephrologist for result interpretation and treatment planning.
Additional Supporting Tests: Creatinine, GFR, or urinalysis to confirm kidney disease diagnosis.
Test Limitations: Non-specific for kidney disease cause; clinical correlation is needed. Sample quality affects sensitivity.
References: NKF Kidney Guidelines, 2023; American Journal of Kidney Diseases, Levey AS, 2022.
